Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 2/10

vs
industry
vs
history
Equity-to-Asset -4.38
HEWA's Equity-to-Asset is ranked lower than
100% of the 339 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.42 vs. HEWA: -4.38 )
Ranked among companies with meaningful Equity-to-Asset only.
HEWA' s Equity-to-Asset Range Over the Past 10 Years
Min: -4.38  Med: 0.37 Max: 0.78
Current: -4.38
-4.38
0.78
Piotroski F-Score: 5
Altman Z-Score: -45.45
Beneish M-Score: -8.69
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating Margin % -12.44
HEWA's Operating Margin % is ranked lower than
96% of the 339 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.94 vs. HEWA: -12.44 )
Ranked among companies with meaningful Operating Margin % only.
HEWA' s Operating Margin % Range Over the Past 10 Years
Min: -66.04  Med: -43.08 Max: -5.97
Current: -12.44
-66.04
-5.97
Net Margin % -13.56
HEWA's Net Margin % is ranked lower than
95% of the 340 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.78 vs. HEWA: -13.56 )
Ranked among companies with meaningful Net Margin % only.
HEWA' s Net Margin % Range Over the Past 10 Years
Min: -64.86  Med: -51.4 Max: 2.81
Current: -13.56
-64.86
2.81
ROA % -147.93
HEWA's ROA % is ranked lower than
99% of the 342 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.31 vs. HEWA: -147.93 )
Ranked among companies with meaningful ROA % only.
HEWA' s ROA % Range Over the Past 10 Years
Min: -307.05  Med: -155.23 Max: 3.18
Current: -147.93
-307.05
3.18
ROC (Joel Greenblatt) % -354.40
HEWA's ROC (Joel Greenblatt) % is ranked lower than
98% of the 341 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 14.43 vs. HEWA: -354.40 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
HEWA' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -958.37  Med: -473.65 Max: -91.09
Current: -354.4
-958.37
-91.09
3-Year Revenue Growth Rate -15.80
HEWA's 3-Year Revenue Growth Rate is ranked lower than
95% of the 313 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.10 vs. HEWA: -15.80 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
HEWA' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -61.8  Med: -29.6 Max: 82.5
Current: -15.8
-61.8
82.5
3-Year EBITDA Growth Rate -48.90
HEWA's 3-Year EBITDA Growth Rate is ranked lower than
98% of the 281 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 6.20 vs. HEWA: -48.90 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
HEWA' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -79.3  Med: -33.6 Max: 101.8
Current: -48.9
-79.3
101.8
3-Year EPS without NRI Growth Rate -49.50
HEWA's 3-Year EPS without NRI Growth Rate is ranked lower than
96% of the 249 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.20 vs. HEWA: -49.50 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
HEWA' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: -54.85 Max: 26.7
Current: -49.5
0
26.7
GuruFocus has detected 5 Warning Signs with HealthWarehouse.com Inc $HEWA.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» HEWA's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with HEWA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Retail - Defensive » Pharmaceutical Retailers    NAICS: 446110    SIC: 5912
Compare:OTCPK:ASDS, OTCPK:OMHE, NAS:CJJD, OTCBB:COCP, NAS:PETS, NYSE:GNC, OTCPK:CLCGY, OTCPK:JCOUF, OTCPK:SDGCF, NYSE:RAD, OTCPK:RADLY, NAS:WBA » details
HealthWarehouse.com Inc is a retail mail-order pharmacy. The Company is a U.S. licensed virtual retail pharmacy and healthcare e-commerce company that sells brand name and generic prescription drugs as well as OTC medical products.

HealthWarehouse.com Inc was incorporated in the State of Delaware on August 5, 1998. The Company is a U.S. licensed virtual retail pharmacy and healthcare e-commerce company that sells brand name and generic prescription drugs as well as over-the-counter medical products. The Company is presently licensed as a mail-order pharmacy for sales to 50 states in the United States and the District of Columbia. Currently, it sells prescription drugs both brand name and generic; diabetic supplies including glucometers, lancets, syringes and test strips; OTC medications covering allergy and sinus to pain and fever to smoking cessation aids; diet and nutritional products including supplements, weight loss aids, and vitamins and minerals and pet medications. It also provides 90-day return policy with no restocking fees, and 100% free standard shipping on all orders. It sells directly to individual consumers who purchase prescription medications and OTC products. The Company's online pharmacy offers the following advantages: Legitimacy, Convenience, Selection, Information, Privacy, Value, and Customer Service. The Company's business is centered on Internet-based advertising. The Company filed for a trademark on the name HealthWarehouse.com on August 14, 2007 with the U.S. Patent and Trademark Office, which trademark was granted with a registration date of May 19, 2009. The Company's competitors in the segment include chain drugstores, mail order pharmacies, mass market retailers, warehouse clubs and supermarkets. Federal and state laws and regulations govern many aspects of its business and are specific to pharmacies and the sale of OTC drugs.

Ratios

vs
industry
vs
history
PS Ratio 0.83
HEWA's PS Ratio is ranked lower than
72% of the 394 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.50 vs. HEWA: 0.83 )
Ranked among companies with meaningful PS Ratio only.
HEWA' s PS Ratio Range Over the Past 10 Years
Min: 0.26  Med: 1.36 Max: 29.92
Current: 0.83
0.26
29.92
Current Ratio 0.12
HEWA's Current Ratio is ranked lower than
99% of the 324 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.20 vs. HEWA: 0.12 )
Ranked among companies with meaningful Current Ratio only.
HEWA' s Current Ratio Range Over the Past 10 Years
Min: 0.1  Med: 1.26 Max: 3.42
Current: 0.12
0.1
3.42
Quick Ratio 0.08
HEWA's Quick Ratio is ranked lower than
99% of the 324 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.70 vs. HEWA: 0.08 )
Ranked among companies with meaningful Quick Ratio only.
HEWA' s Quick Ratio Range Over the Past 10 Years
Min: 0.06  Med: 0.72 Max: 3.08
Current: 0.08
0.06
3.08
Days Inventory 22.06
HEWA's Days Inventory is ranked higher than
70% of the 328 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 38.50 vs. HEWA: 22.06 )
Ranked among companies with meaningful Days Inventory only.
HEWA' s Days Inventory Range Over the Past 10 Years
Min: 15.79  Med: 29.16 Max: 65.88
Current: 22.06
15.79
65.88
Days Sales Outstanding 2.28
HEWA's Days Sales Outstanding is ranked higher than
87% of the 249 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 13.60 vs. HEWA: 2.28 )
Ranked among companies with meaningful Days Sales Outstanding only.
HEWA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 2.28  Med: 6.9 Max: 43.82
Current: 2.28
2.28
43.82
Days Payable 184.35
HEWA's Days Payable is ranked higher than
94% of the 253 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 47.14 vs. HEWA: 184.35 )
Ranked among companies with meaningful Days Payable only.
HEWA' s Days Payable Range Over the Past 10 Years
Min: 80.31  Med: 183.95 Max: 372.47
Current: 184.35
80.31
372.47

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -17.10
HEWA's 3-Year Average Share Buyback Ratio is ranked lower than
92% of the 195 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: -0.60 vs. HEWA: -17.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HEWA' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -84.4  Med: -37.2 Max: -6.2
Current: -17.1
-84.4
-6.2

Valuation & Return

vs
industry
vs
history
Price-to-Median-PS-Value 0.59
HEWA's Price-to-Median-PS-Value is ranked higher than
89% of the 381 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.14 vs. HEWA: 0.59 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
HEWA' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.23  Med: 1.01 Max: 12.65
Current: 0.59
0.23
12.65
Earnings Yield (Greenblatt) % -12.01
HEWA's Earnings Yield (Greenblatt) % is ranked lower than
95% of the 475 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 6.00 vs. HEWA: -12.01 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
HEWA' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -12.02  Med: 21.8 Max: 162.9
Current: -12.01
-12.02
162.9

More Statistics

Revenue (TTM) (Mil) $10.39
EPS (TTM) $ -0.05
Beta-4.26
Short Percentage of Float0.03%
52-Week Range $0.19 - 0.85
Shares Outstanding (Mil)42.65
» More Articles for HEWA

Headlines

Articles On GuruFocus.com
No related article found.

More From Other Websites
HealthWarehouse.com, Inc. :HEWA-US: Earnings Analysis: Q4, 2016 By the Numbers : March 29, 2017 Mar 29 2017
HEALTHWAREHOUSE.COM, INC. Financials Mar 24 2017
HEALTHWAREHOUSE.COM, INC. Files SEC form 10-K, Annual Report Mar 21 2017
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Mar 13 2017
HealthWarehouse.com Reports 4Q and Full Year 2016 Results Mar 13 2017
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Mar 03 2017
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K/A, Change in Directors or Principal Officers Feb 16 2017
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Change in Directors or Principal Officers Feb 06 2017
​Greater Cincinnati health care firm replaces CEO Jan 23 2017
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Dec 06 2016
HEALTHWAREHOUSE.COM, INC. Files SEC form 10-Q, Quarterly Report Nov 08 2016
HealthWarehouse.com, Inc. :HEWA-US: Earnings Analysis: Q3, 2016 By the Numbers : November 8, 2016 Nov 08 2016
HealthWarehouse.com Reports Third-Quarter Earnings Nov 07 2016
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in... Oct 14 2016
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Oct 07 2016
SeeThruEquity Initiates Coverage on HealthWarehouse.com, Inc. (HEWA) with a Price Target of $0.65 Oct 03 2016
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Change in Directors or Principal Officers Sep 15 2016
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Changes in Control or Registrant, Submission of... Sep 09 2016
Rx Investor Value Slate of Stockholder-Nominated Directors Elected to Board of Directors at... Sep 07 2016
HEALTHWAREHOUSE.COM, INC. Files SEC form 8-K, Results of Operations and Financial Condition,... Aug 29 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)